Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

A Fermi-degenerate three-dimensional optical lattice clock.

Campbell SL, Hutson RB, Marti GE, Goban A, Darkwah Oppong N, McNally RL, Sonderhouse L, Robinson JM, Zhang W, Bloom BJ, Ye J.

Science. 2017 Oct 6;358(6359):90-94. doi: 10.1126/science.aam5538.

PMID:
28983047
2.

Systematic evaluation of an atomic clock at 2 × 10(-18) total uncertainty.

Nicholson TL, Campbell SL, Hutson RB, Marti GE, Bloom BJ, McNally RL, Zhang W, Barrett MD, Safronova MS, Strouse GF, Tew WL, Ye J.

Nat Commun. 2015 Apr 21;6:6896. doi: 10.1038/ncomms7896.

3.

An optical lattice clock with accuracy and stability at the 10(-18) level.

Bloom BJ, Nicholson TL, Williams JR, Campbell SL, Bishof M, Zhang X, Zhang W, Bromley SL, Ye J.

Nature. 2014 Feb 6;506(7486):71-5. doi: 10.1038/nature12941. Epub 2014 Jan 22.

PMID:
24463513
4.

Meta-analysis of randomized controlled trials on the risk of bleeding with dabigatran.

Bloom BJ, Filion KB, Atallah R, Eisenberg MJ.

Am J Cardiol. 2014 Mar 15;113(6):1066-74. doi: 10.1016/j.amjcard.2013.11.049. Epub 2013 Dec 24. Review.

PMID:
24440332
5.

Comparison of two independent Sr optical clocks with 1×10(-17) stability at 10(3) s.

Nicholson TL, Martin MJ, Williams JR, Bloom BJ, Bishof M, Swallows MD, Campbell SL, Ye J.

Phys Rev Lett. 2012 Dec 7;109(23):230801. Epub 2012 Dec 5.

PMID:
23368177
6.

Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate.

Stock TC, Bloom BJ, Wei N, Ishaq S, Park W, Wang X, Gupta P, Mebus CA.

J Rheumatol. 2012 Apr;39(4):720-7. doi: 10.3899/jrheum.110874. Epub 2012 Mar 1.

PMID:
22382341
7.

Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.

Lumry WR, Li HH, Levy RJ, Potter PC, Farkas H, Moldovan D, Riedl M, Li H, Craig T, Bloom BJ, Reshef A.

Ann Allergy Asthma Immunol. 2011 Dec;107(6):529-37. doi: 10.1016/j.anai.2011.08.015. Epub 2011 Oct 5.

PMID:
22123383
8.

Measurement of optical Feshbach resonances in an ideal gas.

Blatt S, Nicholson TL, Bloom BJ, Williams JR, Thomsen JW, Julienne PS, Ye J.

Phys Rev Lett. 2011 Aug 12;107(7):073202. Epub 2011 Aug 12.

PMID:
21902391
9.

Dosing celecoxib in pediatric patients with juvenile rheumatoid arthritis.

Krishnaswami S, Hutmacher MM, Robbins JL, Bello A, West C, Bloom BJ.

J Clin Pharmacol. 2012 Aug;52(8):1134-49. doi: 10.1177/0091270011412184. Epub 2011 Aug 30.

PMID:
21878579
10.

Intra-articular corticosteroid therapy for juvenile idiopathic arthritis: report of an experiential cohort and literature review.

Bloom BJ, Alario AJ, Miller LC.

Rheumatol Int. 2011 Jun;31(6):749-56. doi: 10.1007/s00296-010-1365-x. Epub 2010 Feb 14. Review.

PMID:
20155422
11.

Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial.

Coombs JH, Bloom BJ, Breedveld FC, Fletcher MP, Gruben D, Kremer JM, Burgos-Vargas R, Wilkinson B, Zerbini CA, Zwillich SH.

Ann Rheum Dis. 2010 Feb;69(2):413-6. doi: 10.1136/ard.2009.108159. Epub 2009 Jul 8.

PMID:
19587388
12.

The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo.

Kremer JM, Bloom BJ, Breedveld FC, Coombs JH, Fletcher MP, Gruben D, Krishnaswami S, Burgos-Vargas R, Wilkinson B, Zerbini CA, Zwillich SH.

Arthritis Rheum. 2009 Jul;60(7):1895-905. doi: 10.1002/art.24567. Erratum in: Arthritis Rheum. 2012 May;64(5):1487.

13.

Persistent elevation of fibrin D-dimer predicts longterm outcome in systemic juvenile idiopathic arthritis.

Bloom BJ, Alario AJ, Miller LC.

J Rheumatol. 2009 Feb;36(2):422-6. doi: 10.3899/jrheum.070600.

PMID:
19040298
14.

A prospective study comparing celecoxib with naproxen in children with juvenile rheumatoid arthritis.

Foeldvari I, Szer IS, Zemel LS, Lovell DJ, Giannini EH, Robbins JL, West CR, Steidle G, Krishnaswami S, Bloom BJ.

J Rheumatol. 2009 Jan;36(1):174-82. doi: 10.3899/jrheum.080073.

PMID:
19012356
16.

Anti-endothelial cell antibodies are prevalent in juvenile idiopathic arthritis: implications for clinical disease course and pathogenesis.

Bloom BJ, Toyoda M, Petrosian A, Jordan S.

Rheumatol Int. 2007 May;27(7):655-60. Epub 2006 Dec 13.

PMID:
17165085
17.

Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study.

Sandborn WJ, Stenson WF, Brynskov J, Lorenz RG, Steidle GM, Robbins JL, Kent JD, Bloom BJ.

Clin Gastroenterol Hepatol. 2006 Feb;4(2):203-11.

PMID:
16469681
18.
20.

Synovial fluid levels of E-selectin and intercellular adhesion molecule-1: relationship to joint inflammation in children with chronic arthritis.

Bloom BJ, Nelson SM, Alario AJ, Miller LC, Schaller JG.

Rheumatol Int. 2002 Sep;22(5):175-7. Epub 2002 Jun 7.

PMID:
12215860
21.

Soluble adhesion molecules in pediatric rheumatic diseases.

Bloom BJ, Miller LC, Blier PR.

J Rheumatol. 2002 Apr;29(4):832-6.

PMID:
11950029
22.

Sleep and its relationship to pain, dysfunction, and disease activity in juvenile rheumatoid arthritis.

Bloom BJ, Owens JA, McGuinn M, Nobile C, Schaeffer L, Alario AJ.

J Rheumatol. 2002 Jan;29(1):169-73.

PMID:
11824956
23.

New drug therapies for the pediatric rheumatic diseases.

Bloom BJ.

Curr Opin Rheumatol. 2001 Sep;13(5):410-4. Review.

PMID:
11604597
25.

Lack of Borrelia burgdorferi DNA in synovial samples from patients with antibiotic treatment-resistant Lyme arthritis.

Carlson D, Hernandez J, Bloom BJ, Coburn J, Aversa JM, Steere AC.

Arthritis Rheum. 1999 Dec;42(12):2705-9.

26.

Soluble adhesion molecules in juvenile rheumatoid arthritis.

Bloom BJ, Miller LC, Tucker LB, Schaller JG, Blier PR.

J Rheumatol. 1999 Sep;26(9):2044-8.

PMID:
10493690
27.

Felty syndrome complicating juvenile rheumatoid arthritis.

Bloom BJ, Smith P, Alario AJ.

J Pediatr Hematol Oncol. 1998 Sep-Oct;20(5):511-3.

PMID:
9787332
28.

Fibrin D-dimer as a marker of disease activity in systemic onset juvenile rheumatoid arthritis.

Bloom BJ, Tucker LB, Miller LC, Schaller JG.

J Rheumatol. 1998 Aug;25(8):1620-5.

PMID:
9712110
29.

Neurocognitive abnormalities in children after classic manifestations of Lyme disease.

Bloom BJ, Wyckoff PM, Meissner HC, Steere AC.

Pediatr Infect Dis J. 1998 Mar;17(3):189-96.

PMID:
9535244
30.

Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis.

Nocton JJ, Bloom BJ, Rutledge BJ, Persing DH, Logigian EL, Schmid CH, Steere AC.

J Infect Dis. 1996 Sep;174(3):623-7.

PMID:
8769624
31.

Bicipital synovial cysts in juvenile rheumatoid arthritis: clinical description and sonographic correlation.

Bloom BJ, Tucker LB, Miller LC, McCauley RG, Schaller JG.

J Rheumatol. 1995 Oct;22(10):1953-5.

PMID:
8991997
32.

von Willebrand factor in juvenile dermatomyositis.

Bloom BJ, Tucker LB, Miller LC, Schaller JG.

J Rheumatol. 1995 Feb;22(2):320-5.

PMID:
7738956
33.

Magnetic resonance imaging in staphylococcal osteomyelitis with negative bone scan.

Bloom BJ, Miller LC, Tucker LB, Schaller JG.

Clin Pediatr (Phila). 1994 Nov;33(11):686-7. No abstract available.

PMID:
7859429
34.

Worsening of the rash of juvenile dermatomyositis with hydroxychloroquine therapy.

Bloom BJ, Tucker LB, Klein-Gitelman M, Miller LC, Schaller JG.

J Rheumatol. 1994 Nov;21(11):2171-2. No abstract available.

PMID:
7726968

Supplemental Content

Loading ...
Support Center